Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia

Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia

Abstract Background Little data exists predicting the resistance to actinomycin D (Act-D) single-agent for gestational trophoblastic neoplasia (GTN). The objective was to determine the overall success of pulse Act-D and the factors predictive of resistance to pulse Act-D in the treatment of low-risk...

Full description

Bibliographic Details
Main Authors: Lei Li, Xirun Wan, Fengzhi Feng, Tong Ren, Junjun Yang, Jun Zhao, Fang Jiang, Yang Xiang
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Cancer
Subjects:
Actinomycin D
Gestational trophoblastic neoplasia
Transvaginal ultrasound
β-hCG
Online Access:http://link.springer.com/article/10.1186/s12885-018-4512-5

Internet

http://link.springer.com/article/10.1186/s12885-018-4512-5

Similar Items